Xylo Technologies Ltd (XYLO)

Market Cap	2.36M
Revenue (ttm)	57.64M
Net Income (ttm)	-15.99M
Shares Out	732.07K
EPS (ttm)	-23.29
PE Ratio	n/a
Forward PE	0.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,064
Open	3.201
Previous Close	3.110
Day's Range	3.100 - 3.458
52-Week Range	2.700 - 10.430
Beta	1.49
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 27, 2024

About XYLO

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 84
• Stock Exchange: NASDAQ
• Ticker Symbol: XYLO
• Website: https://www.medigus.com

Financial Performance

In 2023, Xylo Technologies's revenue was $91.72 million, a decrease of -0.15% compared to the previous year's $91.86 million. Losses were -$16.03 million, 63.3% more than in 2022.

Financial numbers in USD